On the other hand, the cardiac cGMP/PKG pathway is impaired in response to obesity-related type 2 diabetes, and activating the PKG pathway dramatically attenuated pathological cardiomyocyte stiffness and type 2 diabetes mellitus-associated cardiac dysfunction [74, 75]. This evidence concerns the gene PRKG1 and obesity disorder.